Skip to Main Content

Paper Details

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer.
Prostate Cancer Prostatic Dis
33
2021
Author NameAffiliation
David I QuinnUniversity of Southern California
David I QuinnNorris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California
  • 1 - 2

Datasets

Release 1.2